Precision Neuroscience Corporation announced a strategic partnership with Medtronic (MDT) to advance neurosurgery, leveraging Precision’s brain-computer interface technology and Medtronic’s Neuroscience portfolio. The companies will co-develop an integrated solution that combines Precision’s Layer 7 cortical interface with the Medtronic StealthStation surgical navigation system, Precision stated. “Our work with Medtronic represents an important step toward advancing how the field understands and interacts with the human brain. Precision’s minimally invasive approach allows this technology to reach widespread clinical use, opening the door to new insights and breakthroughs. Partnering with Medtronic accelerates that path- Medtronic’s Cranial & Spinal Technologies business provides ubiquitous and trusted platforms in neurosurgery, and integrating our technology into a tool surgeons already rely on represents a step change in how quickly we can bring these capabilities into everyday practice,” said Michael Mager, CEO of Precision Neuroscience.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic announces FDA clearance of MiniMed Go Smart MDI system
- Medtronic price target raised to $112 from $111 at Bernstein
- Medtronic price target raised to $116 from $111 at Barclays
- 3 Best Dividend Aristocrat Stocks to Buy Now, 01/07/2026
- CoreWeave initiated, Shopify downgraded: Wall Street’s top analyst calls
